Digital Subtraction Angiography Market

By Product Type;

Instruments and Contrast Medium

By Type;

Intravenous Digital Subtraction Angiography and Intra-arterial Digital Subtraction Angiography

By End User;

Medium-sized & Large Hospitals, Diagnostic Centers, Outpatient Clinics, and Laboratories in Universities

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn147373363 Published Date: June, 2025 Updated Date: August, 2025

Digital Subtraction Angiography Market Overview

Digital Subtraction Angiography Market (USD Million)

Digital Subtraction Angiography Market was valued at USD 457.94 million in the year 2024. The size of this market is expected to increase to USD 735.36 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.0%.


Digital Subtraction Angiography Market

*Market size in USD million

CAGR 7.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.0 %
Market Size (2024)USD 457.94 Million
Market Size (2031)USD 735.36 Million
Market ConcentrationMedium
Report Pages339
457.94
2024
735.36
2031

Major Players

  • GE Healthcare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Philips Healthcare
  • Shimadzu Corporation
  • Hitachi Medical Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Digital Subtraction Angiography Market

Fragmented - Highly competitive market without dominant players


The Digital Subtraction Angiography Market is witnessing notable expansion driven by the increasing demand for minimally invasive diagnostic imaging. As hospitals and diagnostic centers move toward precision diagnostics, over 60% of neurovascular and cardiovascular procedures now rely on advanced imaging like DSA. The modality’s ability to provide high-contrast vascular imaging makes it a preferred tool in interventional radiology and vascular surgery.

Rising Prevalence of Vascular Disorders
The market is fueled by the growing burden of vascular diseases such as aneurysms, stenosis, and embolisms. Nearly 45% of patients undergoing cerebral or peripheral angiographic procedures are now diagnosed using DSA-based technologies. This trend is supported by the rising geriatric population and lifestyle-related conditions contributing to vascular complications, boosting the adoption of precise vascular imaging modalities.

Technological Advancements Enhancing Efficiency
Technological innovations in image resolution, real-time visualization, and radiation dose management have significantly improved the efficacy of digital subtraction angiography. Over 50% of installed systems now include flat-panel detectors and advanced software algorithms, allowing for enhanced diagnostic confidence and workflow efficiency. Integration with AI for real-time interpretation is also being explored, promising faster and more accurate evaluations.

Increasing Clinical Applications and Procedures
Digital subtraction angiography is increasingly utilized in diverse clinical areas including oncology, neurology, and cardiology. Approximately 40% of oncology-related vascular interventions involve DSA due to its detailed imaging of tumor-feeding vessels. This expansion into multi-disciplinary use cases is pushing the demand across hospital settings and specialty clinics focused on interventional procedures.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Type
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Digital Subtraction Angiography Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Technological Advancements
        2. Increasing Prevalence of Cardiovascular Diseases
        3. Growing Demand for Minimally Invasive Procedures
        4. Rising Adoption of Interventional Radiology Techniques
        5. Emphasis on Early Disease Detection
      2. Restraints
        1. High Cost of Digital Subtraction Angiography Systems
        2. Limited Availability in Developing Regions
        3. Regulatory Challenges and Compliance Requirements
        4. Lack of Skilled Healthcare Professionals
        5. Potential Risks Associated with Ionizing Radiation
      3. Opportunities
        1. Expansion of Healthcare Infrastructure in Emerging Markets
        2. Technological Innovations in Imaging Systems
        3. Strategic Collaborations and Partnerships
        4. Integration with Artificial Intelligence and Machine Learning
        5. Increasing Focus on Preventive Healthcare Strategies
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Digital Subtraction Angiography Market, By Product Type, 2021 - 2031 (USD Million)
      1. Instruments
      2. Contrast Medium
    2. Digital Subtraction Angiography Market, By Type, 2021 - 2031 (USD Million)

      1. Intravenous Digital Subtraction Angiography

      2. Intra-Arterial Digital Subtraction Angiography

    3. Digital Subtraction Angiography Market, By End User, 2021 - 2031 (USD Million)
      1. Medium-sized & Large Hospitals
      2. Diagnostic Centers
      3. Outpatient Clinics
      4. Laboratories in Universities
    4. Digital Subtraction Angiography Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
      5. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
  6. Competitive Landscape
    1. Company Profiles
      1. GE Healthcare
      2. Siemens Healthineers
      3. Canon Medical Systems Corporation
      4. Philips Healthcare
      5. Shimadzu Corporation
      6. Hitachi Medical Corporation
  7. Analyst Views
  8. Future Outlook of the Market